Stockscreener 앱 받기
354.85
0.14%
-0.50
전일 마감가:
$355.35
열려 있는:
$355.17
하루 거래량:
1.40M
Relative Volume:
1.02
시가총액:
$68.84B
수익:
$321.33B
순이익/손실:
$1.57B
주가수익비율:
44.63
EPS:
7.9518
순현금흐름:
$3.21B
1주 성능:
+5.71%
1개월 성능:
+3.84%
6개월 성능:
+19.15%
1년 성능:
+47.31%
1일 변동 폭
$352.42
$356.87
1주일 범위
$333.95
$356.87
52주 변동 폭
$237.71
$377.54
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
COR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
354.85 | 68.94B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
840.46 | 104.19B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
212.45 | 50.72B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
79.98 | 9.19B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5902 | 840.28M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Aug Spikes: What dividend growth rate does Cencora Inc offerJuly 2025 Macro Moves & Real-Time Volume Analysis - baoquankhu1.vn
Cencora Sets Date to Reveal Q1 Results as Investors Brace for Early Look - MyChesCo
Cencora Expands Credit Facilities to Finance OneOncology Deal - TipRanks
Cencora Updates Multiple Financing Agreements With Major Lenders - TradingView — Track All Markets
Cencora (NYSE: COR) expands credit lines to fund OneOncology acquisition - Stock Titan
Portfolio Recap: Is RCEL stock a good dividend stockJuly 2025 Macro Moves & Verified Trade Idea Suggestions - baoquankhu1.vn
NJ Judge Orders Mediation In Merck-Cencora Indemnity Fight - Law360
10 Biggest Healthcare Companies - Investopedia
Aug Reactions: Is Cencora Inc stock a defensive play in 2025Oil Prices & Long-Term Safe Return Strategies - Bộ Nội Vụ
Breakout Zone: Will Cencora Inc. stock benefit from AI adoptionMarket Risk Report & Technical Confirmation Alerts - Bộ Nội Vụ
Cencora Inc.: Quiet Rally, Solid Fundamentals – Is This Healthcare Stock Still Underpriced? - AD HOC NEWS
Baird Adjusts Cencora Price Target to $415 From $392, Maintains Outperform Rating - marketscreener.com
What to expect from Cencora's next quarterly earnings report - MSN
Video Forum: Tim Cernohous, Cencora - Mass Market Retailers
Nordea Investment Management AB Increases Stock Holdings in Cencora, Inc. $COR - MarketBeat
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $164,000 Stock Position in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Position Cut by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Tema Etfs LLC Invests $2.04 Million in Cencora, Inc. $COR - MarketBeat
First Horizon Corp Makes New $3.01 Million Investment in Cencora, Inc. $COR - MarketBeat
Published on: 2026-01-13 06:24:30 - Улправда
AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies - GlobeNewswire Inc.
Cencora, Inc. (COR) Stock Analysis: Exploring a 15.56% Potential Upside Amid Strong Analyst Confidence - DirectorsTalk Interviews
Aug Swings: Is Cencora Inc subject to activist investor interestPortfolio Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Washington Trust Bank Has $14.56 Million Position in Cencora, Inc. $COR - MarketBeat
SG Americas Securities LLC Has $5.40 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
Spire Wealth Management Lowers Position in Cencora, Inc. $COR - MarketBeat
Nisa Investment Advisors LLC Raises Stake in Cencora, Inc. $COR - MarketBeat
Jim Cramer says “I like Cencora a lot” but notes “Cardinal Health’s got them all beat” - MSN
Cencora (COR) Valuation Check As Share Price Momentum Cools After Recent Gains - Yahoo Finance
What to Expect From Cencora's Next Quarterly Earnings Report - Barchart.com
PRN_FinancialWrapper | PR NewswireWhat to Expect From Cencora's Next Quarterly Earnings Report - FinancialContent
Why Cencora Inc. stock is rated strong buyPrice Action & Daily Profit Maximizing Trade Tips - ulpravda.ru
Why Cencora Inc. stock attracts high net worth investorsTrade Exit Report & Fast Gain Swing Trade Alerts - Улправда
Is Cencora Inc. stock a buy for dividend growth2025 Price Targets & AI Driven Price Predictions - ulpravda.ru
Is It Too Late To Consider Cencora (COR) After A 236% Five Year Run? - simplywall.st
Cencora Inc.: Quiet Rally, Big Expectations – Is The Stock Still A Buy After Its Recent Run? - AD HOC NEWS
How geopolitical tensions affect Cencora Inc. stockWeekly Profit Analysis & Smart Investment Allocation Tips - ulpravda.ru
Will Cencora Inc. stock recover faster than marketJuly 2025 Patterns & Fast Exit and Entry Trade Guides - ulpravda.ru
Will Cencora Inc. (ABG) stock outperform energy sector in 2025Recession Risk & Advanced Technical Signal Analysis - ulpravda.ru
Here's Why You Should Retain Cencora Stock in Your Portfolio Now - The Globe and Mail
Why Cencora (COR) is a Top Value Stock for the Long-Term - Yahoo Finance
Moran Wealth Management LLC Sells 3,180 Shares of Cencora, Inc. $COR - MarketBeat
CX Institutional Purchases 12,964 Shares of Cencora, Inc. $COR - MarketBeat
Why Cencora Inc. stock attracts HNW investorsHigh Frequency Trading Trends & We Spotted the Next Tesla – See Inside - ulpravda.ru
Here's Why Cencora (COR) is a Strong Growth Stock - Yahoo Finance
Cencora, Inc. $COR Stock Position Lowered by Sivik Global Healthcare LLC - MarketBeat
Robeco Institutional Asset Management B.V. Purchases 20,713 Shares of Cencora, Inc. $COR - MarketBeat
Cencora bets big on oncology platform in $5 billion OneOncology deal - MSN
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release - MarketScreener
Who Owns Cencora? Top Shareholders and Recent Insider Activity - TIKR.com
Cencora stock price target lowered to $360 by BofA on valuation concerns - Investing.com Nigeria
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
2.43%
자본화:
|
볼륨(24시간):